Publication | Open Access
Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-κB signaling pathways
34
Citations
28
References
2016
Year
S100A9 might be a significant role for predicting osteosarcoma prognosis and down-regulation of S100A9 could be used as a potential target for gene therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1